• Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
Search
FDAReview.org
  • Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About

Monthly Archives: June 2018

EpiPen Pricing Controversy Reveals Ignorance about Market Competition

Raymond March - June 22, 2018
0

FDA Moves Closer to Approving Ecstasy

Raymond March - June 19, 2018
0

Right-to-Try Law Signed!

Raymond March - June 18, 2018
0
© 2018 Independent Institute, 100 Swan Way, Oakland CA 94621-1428 | (510) 632‑1366.
Edit with Live CSS
Save
Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.